Business and Administration Personnel

Kathryn Melsop

Director of Business Operations & Administration

 Kathryn oversees finance, business development and administrative operations for the Laboratory for Cell & Gene Medicine. She has over 20 years of management experience across diverse clinical research and public health areas with a focus on organizational and business development, strategic planning, human resources and team development. Kathryn has a Bachelor of Science degree in Zoology from Miami University and a Master of Science degree in Biology from The University of Cincinnati. Previous roles include: Administrative Director for the California Maternal Quality Care Collaborative (CMQCC) in the Division of Neonatology, Department of Pediatrics; Stem Cell Research Oversight Manager in the Research Compliance Office at Stanford University and General Manager for The Stem Cell Advisors, Inc.

Jasminka Jakovljevic

Administrative Associate I

Jasminka Jakovljević joined the Laboratory for Cell and Gene Medicine as Materials Management Specialist in May 2016. She is responsible for the materials management and administrative operations of the department.

Prior to joining Stanford, Jasminka was Account Manager at the Société Générale Group in New York, where she was in charge of overseeing and managing the financial and administrative affairs of International Banks and Institutions investing on the U.S. market.

Jasminka studied languages at the Belgrade University in Serbia, and is fluent in English, French and Serbian. 

Navene Hanhan    

Operations Administrator

Navene Hanhan joined the Laboratory for Cell and Gene Medicine as Operations Administrator in March 2017.  She supports both business finance and operations management of the facility. 

Prior to joining the LCGM, she oversaw front desk operations for Stanford Student Housing’s Off Campus Subsidized Housing program.

Navene graduated from San Francisco State University with a BA in English, and Speech Communication.  

Bruce Burnett, PhD, RAC  

Interim Executive Director

Dr. Burnett has over 20 years of pharmaceutical industry experience in quality control/assurance and regulatory affairs.

He recently served as the Acting Director of the Office of Research Support and Compliance (ORSC) at NIH within the Office of the Director and now continues at NIH as an advisor to ORSC.

At Duke, he supports translational research as the Director of the Regulatory Affairs and Quality group. Dr. Burnett came to Duke from Alpha Vax, a vaccine biotech company where he last served as Vice President of Regulatory Affairs and Quality.

Dr. Burnett joined LCGM in November 2018.

 

Danielle Osburg

Administrative Associate II

Danielle Osburg joined the Laboratory for Cell and Gene Medicine in February 2019. She supports the executive director and management team with administrative operations of the facility.

Prior to joining Stanford, Danielle was a Skilled Nursing Authorization Specialist and Quality Program Assistant at Kaiser Permanente. She has spent the last decade working on quality systems, streamlining programs and iniating best practice procedures to improve patient care and experience. Danielle has 20 years of experience in project management, procurement, business finance and program support.

Tuli Cruz

Finance Analyst

Tuli joined the Laboratory for Cell and Gene Medicine in October 2019.  She supports the day-to-day finances of the facility. Prior to joining LCGM, she was the finance analyst for the Division of Pediatric Cardiology at Stanford.  She has worked in healthcare over 20 years and has both clinical and research finance experience.

Tuli is originally from South Florida and graduated from Florida Atlantic University with a BA in Communications and Political Science. She is proud to call California home since 2006.